reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

Bone Biologics Corp

BBLG · Nasdaq

No reporting failures in the last 12 months

It filed on time and stood behind its numbers. Of companies scoring zero, 4.0% were delisted, went bankrupt, restated or stopped filing within the following year.

$7Mpublic float
2021-05-18most recent failure

Score over time

012202220232024202520262022-01-01 · score 22021-05-18 filed late (10-Q) · accounts not ready2021-03-31 filed late (10-K) · accounts not ready2022-04-01 · score 12021-05-18 filed late (10-Q) · accounts not ready

Hover or tap a dot to see the filings behind that score.

Why they said they were late

Bone Biologics Corporation (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021(the “Quarterly Report”) within the prescribed time period without unreasonable effort and expense. The Company requires additional time (1) to complete its presentation of certain information in its financial statements and notes thereto that are contained in the Quarterly Report and (2) to compile supporting documentation for such information. The Company expects that the Quarterly Report will be filed no later than five days after the prescribed filing date

NT 10-Q, filed 2021-05-18 · accounts not ready

What it filed

2021-05-18filed late (10-Q)accounts not ready SEC →

Bone Biologics Corporation (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2021(the “Quarterly Report”) within the prescribed time period without unreasonable effort and expense. The Company requires additional time (1) to complete its presentation of certain information in its financial statements and notes thereto that are contained in the Quarterly Report and (2) to compile supporting documentation for such information. The Company expects that the Quarterly Report will be filed no later than five days after the prescribed filing date

2021-03-31filed late (10-K)accounts not ready SEC →

Bone Biologics Corporation (the “Company”) is unable to file its Annual Report on Form 10-K for the year ended December 31, 2020 (the “Annual Report”) within the prescribed time period without unreasonable effort and expense. The Company requires additional time (1) to complete its presentation of certain information in its financial statements and notes thereto that are contained in the Annual Report and (2) to compile supporting documentation for such information. The Company expects that the Annual Report will be filed no later than fifteen days after the prescribed filing date

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com